Thrivent Financial For Lutherans Amgen Inc Transaction History

Thrivent Financial For Lutherans

$49.6 Billion
Q2 2024

A detailed history of Thrivent Financial For Lutherans transactions in Amgen Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 625,305 shares of AMGN stock, worth $202 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

625,305

Previous 589,286 6.11%

Holding current value

$202 Million

Previous $168 Million 16.61%

% of portfolio

0.39%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $9.46 Million - $11.5 Million	36,019 Added 6.11%	625,305 $195 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $33.4 Million - $40.3 Million	124,167 Added 26.7%	589,286 $168 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $8.3 Million - $9.36 Million	32,457 Added 7.5%	465,119 $134 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $35.3 Million - $43.8 Million	161,456 Added 59.53%	432,662 $116 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $935,502 - $1.11 Million	4,366 Added 1.64%	271,206 $60.2 Million
Q1 2023 May 17, 2023	SELL	$225.79 - $275.2 $16.9 Million - $20.6 Million	-74,924 Reduced 21.92%	266,840 $64.5 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $22.9 Million - $29.1 Million	-99,825 Reduced 22.61%	341,764 $89.8 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $6.54 Million - $7.37 Million	29,123 Added 7.06%	441,589 $99.5 Million
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $16.1 Million - $17.9 Million	-69,859 Reduced 14.48%	412,466 $100 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $20.7 Million - $22.9 Million	-94,224 Reduced 16.34%	482,325 $117 Million
Q4 2021 Feb 16, 2022	BUY	$198.88 - $227.6 $15.4 Million - $17.6 Million	77,323 Added 15.49%	576,549 $130 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $562,515 - $659,055	-2,650 Reduced 0.53%	499,226 $106 Million
Q2 2021 Sep 24, 2021	BUY	$233.58 - $259.14 $324,676 - $360,204	1,390 Added 0.28%	501,876 $122 Million
Q2 2021 Aug 19, 2021	SELL	$233.58 - $259.14 $6.61 Million - $7.33 Million	-28,285 Reduced 5.35%	500,486 $122 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $20.8 Million - $24.2 Million	93,565 Added 21.5%	528,771 $132 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $8.13 Million - $9.68 Million	37,564 Added 9.45%	435,206 $100 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $8.69 Million - $9.67 Million	37,051 Added 10.28%	397,642 $101 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $45.9 Million - $56.3 Million	232,130 Added 180.7%	360,591 $84.9 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $12.1 Million - $16 Million	-66,129 Reduced 33.98%	128,461 $26 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1.69 Million - $2.17 Million	-8,920 Reduced 4.38%	194,590 $46.9 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $5.47 Million - $6.56 Million	-31,426 Reduced 13.38%	203,510 $39.4 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $244,048 - $286,080	-1,464 Reduced 0.62%	234,936 $43.3 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $420,884 - $474,428	2,327 Added 0.99%	236,400 $44.9 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $3.79 Million - $4.43 Million	21,268 Added 9.99%	234,073 $45.6 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $2.49 Million - $2.8 Million	13,419 Added 6.73%	212,805 $44.1 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $1.52 Million - $1.71 Million	-9,153 Reduced 4.39%	199,386 $36.8 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $2.08 Million - $2.43 Million	-12,256 Reduced 5.55%	208,539 $35.6 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $981,345 - $1.1 Million	5,814 Added 2.7%	220,795 $38.4 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $36 Million - $41.1 Million	214,981	214,981 $40.1 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Amgen Inc Transaction History